TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)
Conditions: Acute Leukemia; CML; Myelodysplasia; Lymphoma Interventions: Procedure: Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate; Drug: Tacrolimus; Drug: Methotrexate; Procedure: Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Mycophenolate Mofetil/Post-Transplant Cyclophosphamide; Drug: Mycophenolate Mofetil; Drug: Cyclophosphamide Sponsors: Medical College of Wisconsin; National Heart, Lung, and Blood Institute (NHLBI); Blood and Marrow Transplant Clinical Trials Network; National Cancer Institute (NCI); National Marrow Donor Program Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Cardiology | Clinical Trials | Heart | Heart Transplant | Leukemia | Lung Transplant | Lymphoma | Methotrexate | Prograf | Research | Stem Cell Therapy | Stem Cells | Study | Tacrolimus | Transplant Surgery | Transplants